Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain
Archivos de la Sociedad Española de Oftalmología (English Edition) · 2023
DOI: 10.1016/j.oftale.2023.04.007 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archivos de la Sociedad Española de Oftalmología (English Edition), 2023. Verfasst von I Bermudez-Castellanos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Oftalmología, Hospital Universitario Río Hortega, Valladolid, Spain. Electronic address: ibermudezcastellanosb@saludcastillayleon.es. Hauptthemen laut MEDLINE: COVID-19, Melanoma, Uveal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
OBJECTIVE: To analyse the impact of the COVID-19 pandemic on the diagnosis and management of uveal melanoma (a tumour included in the Orphanet catalogue of rare diseases) in a Spanish national reference unit for intraocular tumours during the first year of the pandemic. METHOD: An observational retrospective study of patients with uveal melanoma in the National Reference Unit for Adult Intraocular Tumors of the Hospital Clínico Universitario de Valladolid (Spain) was performed, analysing the pre- and post-COVID-19 periods: from March 15, 2019 to March 15, 2020 and from March 16, 2020 to March 16, 2021. Demographic data, diagnostic delay, tumour size, extraocular extension, treatment and evolution were collected. A multivariable logistic regression model was used to identify factors that were associated with the variable: enucleation. RESULTS: Eighty-two patients with uveal melanoma were included, of which 42 (51.21%) belonged to the pre-COVID-19 period and 40(40.78%) to the post-COVID-19 period. An increase in tumour size at diagnosis and in the number of enucleations was observed during the post-COVID-19 period (p < 0.05). Multivariable logistic regression demonstrated that both medium-large tumour size and patients diagnosed in the post-COVID-19 period were independently related to an increased risk of enucleation (OR 250, 95%CI, 27.69-2256.37; p < 0.01 and OR 10; 95%CI, 1.10-90.25; p = 0.04, respectively). CONCLUSIONS: The increase in tumour size observed in uveal melanomas diagnosed during the first year of the COVID-19 pandemic may have favored the increase in the number of enucleations performed during that period.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicio de Oftalmología, Hospital Universitario Río Hortega, Valladolid, Spain. Electronic address: ibermudezcastellanosb@saludcastillayleon.es.
- Servicio de Oftalmología, Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
- Departamento de Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Valladolid, Valladolid, Spain.
- Servicio de Oftalmología, Complejo Asistencial Universitario de Palencia, Palencia, Spain.
Zitieren
APA
Bermudez-Castellanos, I., Saornil Álvarez, M. A., Almaraz Gómez, A., Villoria-Diaz, S., & García Álvarez, C. (2023). Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain. Archivos de la Sociedad Española de Oftalmología (English Edition). https://doi.org/10.1016/j.oftale.2023.04.007
Vancouver
Bermudez-Castellanos I, Saornil Álvarez MA, Almaraz Gómez A, Villoria-Diaz S, García Álvarez C. Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain. Archivos de la Sociedad Española de Oftalmología (English Edition). 2023. doi:10.1016/j.oftale.2023.04.007
BibTeX
@article{BermudezCastellanos2023,
author = {Bermudez-Castellanos, I and Saornil Álvarez, M A and Almaraz Gómez, A and Villoria-Diaz, S and García Álvarez, C},
title = {Impact of COVID-19 on a rare disease (uveal melanoma) in a national reference unit of intraocular tumors in Spain},
journal = {Archivos de la Sociedad Española de Oftalmología (English Edition)},
year = {2023},
doi = {10.1016/j.oftale.2023.04.007}
}
EUVIMED